Document Detail

Potential microRNA-mediated oncogenic intercellular communication revealed by pan-cancer analysis.
MedLine Citation:
PMID:  25403569     Owner:  NLM     Status:  In-Data-Review    
Carcinogenesis consists of oncogenesis and metastasis, and intriguingly microRNAs (miRNAs) are involved in both processes. Although aberrant miRNA activities are prevalent in diverse tumor types, the exact mechanisms for how they regulate cancerous processes are not always clear. To this end, we performed a large-scale pan-cancer analysis via a novel probabilistic approach to infer recurrent miRNA-target interactions implicated in 12 cancer types using data from The Cancer Genome Atlas. We discovered ~20,000 recurrent miRNA regulations, which are enriched for cancer-related miRNAs/genes. Notably, miRNA 200 family (miR-200/141/429) is among the most prominent miRNA regulators, which is known to be involved in metastasis. Importantly, the recurrent miRNA regulatory network is not only enriched for cancer pathways but also for extracellular matrix (ECM) organization and ECM-receptor interactions. The results suggest an intriguing cancer mechanism involving miRNA-mediated cell-to-cell communication, which possibly involves delivery of tumorigenic miRNA messengers to adjacent cells via exosomes. Finally, survival analysis revealed 414 recurrent-prognostic associations, where both gene and miRNA involved in each interaction conferred significant prognostic power in one or more cancer types. Together, our comprehensive pan-cancer analysis provided not only biological insights into metastasis but also brought to bear the clinical relevance of the proposed recurrent miRNA-gene associations.
Yue Li; Zhaolei Zhang
Related Documents :
526929 - Phase ii study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (amsa) in metastatic b...
16732719 - Epothilones in the treatment of cancer.
9807659 - 5-fluorouracil: a pharmacological paradigm in the use of cytotoxics.
10778559 - Paclitaxel-epirubicin in advanced breast cancer.
19203899 - Phase iii trial of folfox plus bevacizumab or cediranib (azd2171) as first-line treatme...
12515569 - Capecitabine: a review of its pharmacology and therapeutic efficacy in the management o...
22832979 - Matrix metalloproteinase-9 expression correlates with prognosis and involved in ovarian...
8653039 - Early detection of prostate cancer. role of prostate-specific antigen.
10639189 - Stat3 mediates il-6-induced neuroendocrine differentiation in prostate cancer cells .
Publication Detail:
Type:  Journal Article     Date:  2014-11-18
Journal Detail:
Title:  Scientific reports     Volume:  4     ISSN:  2045-2322     ISO Abbreviation:  Sci Rep     Publication Date:  2014  
Date Detail:
Created Date:  2014-11-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101563288     Medline TA:  Sci Rep     Country:  England    
Other Details:
Languages:  eng     Pagination:  7097     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Internal migration, mental health, and suicidal behaviors in young rural Chinese.
Next Document:  Mice lacking Axl and Mer tyrosine kinase receptors are susceptible to experimental autoimmune orchit...